UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area

European journal of internal medicine, 2016-07, Vol.32, p.84-90

2016

Link zum Volltext

Verfügbarkeit prüfen

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

Gastroenterology (New York, N.Y. 1943), 2016-07, Vol.151 (1), p.51-69.e14

2016

Link zum Volltext

Verfügbarkeit prüfen

Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Gut, 2020-06, Vol.69 (6), p.1019

2020

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular outcomes associated with use of clarithromycin: population based study

BMJ (Online), 2016-01, Vol.352, p.h6926

2016

Link zum Volltext

Verfügbarkeit prüfen

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

The Lancet (British edition), 2020-04, Vol.395 (10232), p.1259-1267

2020

Link zum Volltext

Verfügbarkeit prüfen

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

Gut, 2016-09, Vol.65 (9), p.1439-1446

2016

Link zum Volltext

Verfügbarkeit prüfen

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

The Lancet (British edition), 2011-03, Vol.377 (9769), p.905-913

2011

Link zum Volltext

Verfügbarkeit prüfen

Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of Helicobacter pylori

Helicobacter (Cambridge, Mass.), 2018-08, Vol.23 (4), p.e12495-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects

British journal of clinical pharmacology, 2013-09, Vol.76 (3), p.455-466

2013

Link zum Volltext

Verfügbarkeit prüfen

The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy

The American journal of gastroenterology, 2016-07, Vol.111 (7), p.949-956

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease

The New England journal of medicine, 2016-03, Vol.374 (13), p.1209-1220

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomised controlled trial: susceptibility‐guided therapy versus empiric bismuth quadruple therapy for first‐line Helicobacter pylori treatment

Alimentary pharmacology & therapeutics, 2019-06, Vol.49 (11), p.1385-1394

2019

Link zum Volltext

Verfügbarkeit prüfen

Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

Clinical gastroenterology and hepatology, 2014-02, Vol.12 (2), p.177-186.e3

2014

Link zum Volltext

Verfügbarkeit prüfen

Micromotor-enabled active drug delivery for in vivo treatment of stomach infection

Nature communications, 2017-08, Vol.8 (1), p.272-9, Article 272

2017

Link zum Volltext

Verfügbarkeit prüfen

Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2007-06, Vol.132 (7), p.2313-2319

2007

Link zum Volltext

Verfügbarkeit prüfen

Combined administration of rifampicin, ethambutol, and clarithromycin for the treatment of tenosynovitis of the hand caused by Mycobacterium avium complex: Case series and literature review

Medicine (Baltimore), 2021-04, Vol.100 (17), p.e25283-e25283

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of Adverse Reactions to Oral Antibiotics Prescribed by Dentists

Journal of dental research, 2019-09, Vol.98 (10), p.1081-1087

2019

Link zum Volltext

Verfügbarkeit prüfen

Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease

American journal of respiratory and critical care medicine, 2015-01, Vol.191 (1), p.96-103

2015

Link zum Volltext

Verfügbarkeit prüfen

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori : a multicentre, open-label, randomised trial

The Lancet (British edition), 2013, Vol.381 (9862), p.205-213

2013

Link zum Volltext

Verfügbarkeit prüfen

Clarithromycin as a “repurposing drug” against MALT lymphoma

British journal of haematology, 2018-09, Vol.182 (6), p.913-915

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects

Journal of clinical pharmacology, 2021-07, Vol.61 (7), p.913-922

2021

Link zum Volltext

Verfügbarkeit prüfen

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients

Clinical gastroenterology and hepatology, 2020-01, Vol.18 (1), p.89-98

2020

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance

The American journal of gastroenterology, 2014-10, Vol.109 (10), p.1595-1602

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 23.070

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17.523)
Mit Volltextzugriff
(18.987)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(14.983)
Life Sciences & Biomedicine
(14.410)
Humans
(11.358)
Pharmacology & Pharmacy
(5.274)
Male
(5.153)
Female
(4.957)
Adult
(3.459)
Antibiotics
(3.441)
Biological And Medical Sciences
(3.441)
Medical Sciences
(3.383)
Middle Aged
(3.234)
Infectious Diseases
(2.632)
Anti-Bacterial Agents - Therapeutic Use
(2.552)
Aged
(2.490)
Anti-Bacterial Agents - Administration & Dosage
(2.341)
Treatment Outcome
(2.341)
Helicobacter Pylori
(2.319)
Pharmacology. Drug Treatments
(2.268)
Drug Therapy
(2.168)
Animals
(2.159)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(8.797)
Journals@Ovid
(8.598)
IngentaConnect Journals
(6.957)
IngentaConnect Journals
(4.840)
Wiley Blackwell Single Titles
(4.334)
SpringerLink_现刊
(3.351)
Wiley Online Library
(3.222)
NUS Single-Journal Subscriptions
(2.930)
Nexis Uni
(2.716)
Ebook Central Perpetual and DDA
(1.877)
eBooks on EBSCOhost
(1.751)
Elsevier ScienceDirect Journals Complete
(1.571)
Factiva
(1.557)
Taylor & Francis
(1.459)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.331)
Taylor & Francis Journals Complete
(1.134)
SAGE Complete
(825)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(771)
Springer Books
(723)
Oxford University Press Journals Current
(593)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Monthly Prescribing Reference
(1.224)
Reactions Weekly
(425)
Alimentary Pharmacology & Therapeutics
(382)
Helicobacter
(335)
Antibiotics
(259)
Plos One
(250)
Journal Of Antimicrobial Chemotherapy
(211)
Drugs
(209)
Clinical Pharmacology And Therapeutics
(184)
The American Journal Of Gastroenterology
(171)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Cardiovascular outcomes associated with use of clarithromycin: population based study

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of Helicobacter pylori

Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects

The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease

Randomised controlled trial: susceptibility‐guided therapy versus empiric bismuth quadruple therapy for first‐line Helicobacter pylori treatment

Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

Micromotor-enabled active drug delivery for in vivo treatment of stomach infection

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori : a multicentre, open-label, randomised trial

Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease

Combined administration of rifampicin, ethambutol, and clarithromycin for the treatment of tenosynovitis of the hand caused by Mycobacterium avium complex: Case series and literature review

Risk of Adverse Reactions to Oral Antibiotics Prescribed by Dentists

Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease

Intra-Amniotic Infection with Ureaplasma parvum Causes Preterm Birth and Neonatal Mortality That Are Prevented by Treatment with Clarithromycin

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori : a multicentre, open-label, randomised trial

Clarithromycin as a “repurposing drug” against MALT lymphoma

Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients

Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance

Suchergebnisse filtern